BIOGEN INC. Proceeds from Issuance of Debt
BIOGEN INC. (BIIB) reported Proceeds from Issuance of Debt of $0 for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-04-23.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfDebt · last filed 2014-04-23
- BIOGEN INC. proceeds from issuance of debt for the quarter ending 2014-03-31 was $0.00, a 100.00% decline year-over-year.
- BIOGEN INC. proceeds from issuance of debt for the quarter ending 2013-03-31 was $200.00M.
- BIOGEN INC. proceeds from issuance of debt for the quarter ending 2012-03-31 was $0.00.
| Period end | Proceeds from Issuance of Debt 3 month |
|---|---|
| 2014-03-31 | $0.00 10-Q · filed 2014-04-23 |
| 2013-03-31 | $200.00M 10-Q · filed 2014-04-23 |
| 2012-03-31 | $0.00 10-Q · filed 2013-04-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |